malformations

Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.

By |2025-06-26T09:07:20-04:00May 1st, 2024|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)

This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.

By |2025-06-26T09:07:24-04:00January 2nd, 2023|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)

Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety

All of our information on the reproductive safety of medications comes from non-randomized studies. However, many of these studies fail to take into consideration other factors associated with maternal psychiatric illness which may also affect outcomes.

By |2022-12-06T12:18:54-04:00December 1st, 2022|Essential Reads, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety

Essential Reads: Folic Acid, Neural Tube Defects, and Congenital Heart Defects

Despite the unequivocal benefits of folic acid supplementation and recommendations urging all women of reproductive age to take folic acid supplements, preconceptual use of folic acid has not increased substantially.

By |2022-08-29T14:34:36-04:00August 24th, 2022|Alternative & Complementary, Essential Reads, Outcomes, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Folic Acid, Neural Tube Defects, and Congenital Heart Defects

Prenatal Valproic Acid (Depakote) Exposure Increases Risk for Neurodevelopmental Disorders

While we have considerable information regarding the teratogenic risk associated with prenatal exposure to various antiepileptic drugs (AEDs), we have considerably less information on the impact of exposure to AEDs on behavioral outcomes in [...]

By |2025-06-26T09:07:38-04:00November 11th, 2020|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Prenatal Valproic Acid (Depakote) Exposure Increases Risk for Neurodevelopmental Disorders

New (But Still Not Enough) Data on Modafinil and Pregnancy

Modafinil (brand name Provigil) is a wake-promoting agent which is used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea.  It is also used in other settings, often in [...]

By |2020-11-17T16:01:54-04:00October 20th, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on New (But Still Not Enough) Data on Modafinil and Pregnancy

Assessing the Reproductive Safety of Antidepressants: Can Non-Randomized Studies Provide the Information We Need?

Perinatal psychiatry is a field in which we treat vulnerable patients, a mother and her child, where both the illness we are treating and the treatments we prescribe have the potential to affect the outcome.  [...]

By |2020-09-09T17:43:09-04:00September 3rd, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Assessing the Reproductive Safety of Antidepressants: Can Non-Randomized Studies Provide the Information We Need?

Another Study on Antidepressants and Birth Defects: Does it Change Our Decision-Making?

Prozac (fluoxetine) was the first SSRI or selective serotonin reuptake inhibitor.  Since its release in 1988, we have been gathering data on the reproductive safety of fluoxetine and other SSRIs.  Over the last 32 years, [...]

By |2020-11-26T08:23:09-04:00August 25th, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Another Study on Antidepressants and Birth Defects: Does it Change Our Decision-Making?

Hispanic Women at High Risk for Neural Tube Defects, May Not Have Adequate Dietary Folic Acid

Because folate deficiency in pregnant women has been associated with an increased risk of neural tube defects, including anencephaly and spina bifida, it is recommended that all women take folic acid supplements before and during [...]

By |2018-11-08T10:35:34-04:00October 30th, 2018|Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Hispanic Women at High Risk for Neural Tube Defects, May Not Have Adequate Dietary Folic Acid

Prenatal Antiepileptic Exposure Increases Risk for Malformations: Does High-Dose Folic Acid Reduce Risk?

The CDC, the U.S. Public Health Service, and the American College of Obstetricians and Gynecologists (ACOG) all recommend that every woman of reproductive age get 400 micrograms (400 mcg) or 0.4 milligrams of folic acid [...]

By |2016-10-24T09:32:36-04:00October 24th, 2016|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Prenatal Antiepileptic Exposure Increases Risk for Malformations: Does High-Dose Folic Acid Reduce Risk?
Go to Top